A hemolytic anemia workup answers three questions in order: is this anemia caused by hemolysis, is the destruction immune or non-immune, and what is the specific cause? The first step uses the reticulocyte count, LDH, haptoglobin, and indirect bilirubin. The second relies on the direct antiglobulin test (DAT). The third is guided by the peripheral smear and targeted tests such as G6PD assays, flow cytometry for PNH, and hemoglobin analysis.
Working systematically avoids two common pitfalls I see in referrals: ordering a scatter of expensive tests before confirming hemolysis, and missing an urgent cause such as thrombotic microangiopathy. This guide sets out a practical sequence.
What Is Hemolytic Anemia?
Hemolytic anemia occurs when red blood cells are destroyed faster than the marrow can replace them. Normal erythrocytes survive about 120 days. A healthy marrow can raise output several-fold, so anemia appears only when survival is shortened substantially or when marrow response is impaired.
Hemolysis is classified by site and mechanism. Intravascular hemolysis destroys cells within the circulation, releasing free hemoglobin, whereas extravascular hemolysis occurs mainly in the spleen and liver. Causes are also grouped as intrinsic (a defect of the erythrocyte itself, usually inherited) or extrinsic (an external attack on a normal cell, usually acquired).
Clinical Clues Before the Labs
The history and examination narrow the field before any blood is drawn. Ask about the tempo of symptoms, dark or cola-colored urine, recent infections, new medications, travel to malaria-endemic areas, recent transfusion, and symptoms triggered by cold. A family history of anemia, jaundice, gallstones at a young age, or splenectomy points toward an inherited cause.
On examination, look for pallor, jaundice, splenomegaly, lymphadenopathy suggesting a lymphoproliferative disorder, and a heart murmur or prosthetic valve. Acrocyanosis in the cold suggests cold agglutinin disease, while leg ulcers can accompany chronic hemolytic states such as sickle cell disease.
Step 1: Confirm Hemolysis
Begin with a CBC, reticulocyte count, and the hemolysis markers. Interpreted together, they establish hemolysis far more reliably than any single value.
| Test | Typical finding in hemolysis | Interpretive notes |
|---|---|---|
| Reticulocyte count | Raised | May be inappropriately low with parvovirus B19, marrow disease, or nutrient deficiency |
| LDH | Raised | Very high in intravascular hemolysis; nonspecific on its own |
| Haptoglobin | Low or undetectable | An acute-phase reactant; can be falsely normal in inflammation and low in liver disease |
| Indirect (unconjugated) bilirubin | Raised | Also raised in Gilbert syndrome |
| Urine hemosiderin / hemoglobinuria | Present | Points to intravascular hemolysis |
| MCV | Often mildly raised | Reticulocytes are larger than mature red cells |
A raised LDH and low haptoglobin together make hemolysis likely, while a normal haptoglobin argues against significant hemolysis. The reticulocyte response reflects the health of the bone marrow, so a low count in the face of hemolysis is itself a clue.
Step 2: Immune or Non-Immune? The Direct Antiglobulin Test
The direct antiglobulin test (DAT), or direct Coombs test, detects IgG antibody or complement (C3d) bound to the patient’s red cells. It is the pivotal branch point in the workup.
- IgG positive (with or without C3d): suggests warm autoimmune hemolytic anemia (AIHA), which may be primary or secondary to lymphoproliferative disease, autoimmune disease, or drugs. Spherocytes are typical on the smear.
- C3d positive, IgG negative: suggests cold agglutinin disease; check a cold agglutinin titer and look for agglutination on the smear.
- DAT positive after transfusion or in a newborn: consider alloimmune hemolysis, such as a delayed transfusion reaction or hemolytic disease of the newborn.
- DAT negative: move to non-immune causes, remembering that a small proportion of AIHA is DAT-negative on standard testing.
Step 3: Read the Peripheral Smear
The blood film is the most informative inexpensive test in the workup. Red cell shape often points straight to the mechanism, so review it personally or with the laboratory when possible.
| Smear finding | Suggests |
|---|---|
| Spherocytes | Warm AIHA or hereditary spherocytosis |
| Schistocytes (fragments) | Microangiopathic hemolysis: TTP, HUS, DIC, or a mechanical heart valve |
| Bite and blister cells, Heinz bodies | Oxidative hemolysis, typically G6PD deficiency |
| Sickle cells | Sickle cell disease |
| Target cells | Hemoglobinopathies such as thalassemia or HbC |
| Agglutination | Cold agglutinin disease |
| Intracellular parasites | Malaria or babesiosis |
Schistocytes with thrombocytopenia are an emergency until proven otherwise. Check platelets, coagulation studies, creatinine, and ADAMTS13 activity, and do not delay treatment for suspected TTP while awaiting results.
Step 4: Targeted Tests for DAT-Negative Hemolysis
Once immune causes are excluded, the history and smear direct further testing:
- G6PD assay: for episodic hemolysis after infection, fava beans, or oxidant drugs. Levels can be falsely normal during acute hemolysis, so repeat after recovery if suspicion remains.
- Hereditary spherocytosis testing: eosin-5-maleimide (EMA) binding by flow cytometry, with family history and splenomegaly as supporting clues.
- Hemoglobin analysis: high-performance liquid chromatography or electrophoresis for sickle cell disease, unstable hemoglobins, and thalassemia.
- PNH flow cytometry: for loss of CD55/CD59 or FLAER binding when hemolysis is intravascular or accompanied by thrombosis or cytopenias.
- Pyruvate kinase and other enzyme assays: for unexplained lifelong nonspherocytic hemolysis.
- Infection testing: blood films or antigen tests for malaria and babesiosis where exposure is possible.
Bone marrow examination is rarely needed, but it is reasonable when the reticulocyte response is inadequate or a lymphoproliferative disorder is suspected. For the broader physiology behind these tests, see our article on the role of red cells in health and disease.
Management Principles
Treatment follows the cause. Warm AIHA is usually treated first with corticosteroids, with rituximab or other immunosuppression for relapsed or refractory disease. Cold agglutinin disease requires avoiding cold exposure, and complement inhibition is an option in some patients. G6PD deficiency is managed by avoiding triggers, while PNH is treated with complement inhibitors. Splenectomy remains useful in selected cases of hereditary spherocytosis.
Across all causes, give folic acid supplementation in chronic hemolysis, transfuse for symptomatic or severe anemia (in AIHA, with close communication with the blood bank), and consider thromboprophylaxis where hemolysis raises clotting risk.
Frequently Asked Questions
What are the first tests in a hemolytic anemia workup?
Start with a CBC, reticulocyte count, peripheral smear, LDH, haptoglobin, and indirect bilirubin. If these confirm hemolysis, the direct antiglobulin test is the next step.
Can hemolysis occur with a normal hemoglobin?
Yes. If the marrow increases production enough, hemoglobin can remain normal, which is called compensated hemolysis. The reticulocyte count and hemolysis markers are still abnormal.
Why can haptoglobin be misleading?
Haptoglobin rises in inflammation, which can mask hemolysis, and falls in liver disease or congenital deficiency without hemolysis. Interpret it alongside LDH, bilirubin, and the reticulocyte count.
When is a hemolytic anemia workup urgent?
It is urgent when schistocytes and low platelets suggest TTP or HUS, when hemoglobin is falling quickly, or when there are signs of intravascular hemolysis such as dark urine. These situations need same-day hematology input.
